President of the African Development Bank, Akinwumi Adesina, wants pharmaceutical companies in Africa to invest in low cost malaria medicines.
At the moment, malaria costs the African continent USD 12 billion every year, according to the African Leaders Malaria Alliance (ALMA).
Adesina told the ALMA meeting that malaria is bad for business and said there is need to invest in local manufacturing of low-cost generic medicines.
The meeting was held on the sidelines of the just concluded 30th African Union Summit. The consensus was that malaria strains national economies and impoverishes households.
He said if medicines can be produced locally and at affordable rates, then access to the general public would be easier and cheaper.
The meeting was also informed that no less than 79% of medicinal drugs consumed on the continent are imported from India and China.
He called upon (African) entrepreneurs in the pharmaceutical industry to invest in local manufacturing of generic medicines.
According to him, the size of Africa’s pharmaceutical market has the potential to reach USD40 billion by 2020.
African nations must renew their commitment and strengthen instruments to attain a malaria-free Africa by 2030, leaders heard today at a high-level briefing held on the margins of the 30th African Union Summit in Addis Ababa.
Malaria Costing Africa USD 12BN Annually
Senior health, finance and foreign affairs officials from across the continent were briefed on the latest findings from the World Health Organization (WHO)’s World Malaria Report 2017 signaling that, for the first time in more than a decade, progress against malaria on the African continent, which accounts for almost 90% of the global malaria burden, has stalled.
“Malaria alone is estimated to rob the continent of US$12 billion per year in lost productivity, investment and associated health care costs. It is therefore critical that we sustain the political commitment, as articulated in our continental Agenda 2063, to eliminate malaria in Africa by 2030 through increased domestic financing, increased access to life-saving malaria interventions, as well as more robust health systems,” said H.E. Moussa Faki Mahamat, the Chairperson of the African Union Commission.
African leaders have committed to eliminating malaria by 2030, as articulated in the Continental development Agenda 2063. Malaria, a treatable and preventable disease, already costs the African continent’s economy US$ 12 billion per year in direct losses, and 1.3% of lost annual GDP growth, an earlier report by the RBM Partnership, Action and Investment to defeat Malaria, has shown.
According to the World Malaria Report 2017, progress across Africa has been uneven, putting at risk the tremendous progress to-date and African leaders’ collective ambition to end the disease. While some African countries have seen a greater than 20% increase in malaria cases and deaths since 2016, others are showing that beating malaria is possible.
“In 2016, just 15 countries carried most of the global malaria burden, together accounting for 80% of all malaria cases and deaths. All but one of these countries are in Africa,” said Dr Pedro Alonso, Director of the WHO Global Malaria Programme. “The report sends a clear warning that we have stopped making progress and that, without urgent action, we risk going backwards.” WHO used the occasion to launch a World Malaria Report 2017 mobile app that provides, at the swipe of a finger, the latest information on malaria policies, financing, interventions and burden in 91 endemic countries.
“African countries are at greatest risk of losing the significant gains made over a decade and must renew efforts to make fighting malaria a priority. Domestic funding needs to be urgently stepped up. These investments — only a fraction of what African nations will save if we succeed in eliminating malaria — will pay off, in millions more lives saved, health systems strengthened, economies grown and the world back on track to end this disease,” said Dr Kesete Admasu, CEO of the RBM Partnership to End Malaria.
Participants also heard that high-burden countries such as Nigeria and the Democratic Republic of the Congo (DRC), which account for 27% and 10% of the global malaria cases, respectively, also face significant gaps in financing their malaria efforts over the next three years. Nigeria faces a financial gap of US$ 1.4 billion, equivalent to 68% of the country’s needs, whereas DRC requires an additional US$ 536 million to fully implement its national malaria strategic plan. Alternatively, several African countries that have stepped up their efforts, such as Senegal and Madagascar, have achieved a greater than 20% decrease in malaria cases in 2016, according to the World Malaria Report 2017.
ALMA was established in 2009 and is made up of 49 African Heads of State. ALMA was established to eliminate malaria by 2030. Its foundation comes from the African Union vision of an Africa free of malaria. It operates under the guardianship of the World Health Organization’s Global Technical Strategy for Malaria 2016-2030.